ro 11-2933 has been researched along with Leukemia L 1210 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canti, G; Mazzoni, A | 1 |
1 other study(ies) available for ro 11-2933 and Leukemia L 1210
| Article | Year |
|---|---|
Reversal of doxorubicin and cisplatin resistance in vivo in murine leukemias by the calcium antagonist RO 11-2933.
Topics: Animals; Calcium Channel Blockers; Cisplatin; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Female; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Propylamines | 1990 |